title: Screening of premalignant cervical lesions for HPV 16 DNA by sandwich and in situ hybridization techniques.
abstract: A series of 97 cervical smears and 69 directed punch biopsies derived from 84 consecutive women prospectively followed-up for cervical HPV (human papillomavirus) infections were studied using the sandwich hybridization and in situ hybridization techniques with HPV 16 DNA probes. The aim was to test the sensitivity and applicability of these two techniques in routine diagnosis of cervical HPV infections from smears. As a measure of specimen adequacy, the number of cells recovered in the cervical scrape was determined along with HPV 16 DNA in the sandwich hybridization test using human pro-alpha 2(I)-collagen gene probe. CIN (cervical intraepithelial neoplasia) was suggested in 56% of the patients by the Pap smear, and disclosed in 65% of the biopsies. HPV 16 DNA was present in 57% of cervical scrapes consistent with CIN, i.e., were of Pap smear classes III or IV. Forty percent of the scrapes not suggestive of CIN, i.e., Pap smear classes I or II, also contained HPV 16 DNA. The detection rate for HPV 16 DNA of the sandwich hybridization method was 89% of that of the in situ method in adequate scrapes, but only 43% in cell-poor specimens. The number of HPV 16 DNA-positive scrapes as compared with the total number of diagnoses obtained by studying also the biopsies was 31/36 (69 patients). The results indicate that the cervical scrape as a noninvasive specimen is applicable for screening of cervical HPV infections, and it can be studied with acceptable sensitivity by the rapid sandwich hybridization technique. However, if a punch biopsy is indicated it should be studied using the in situ hybridization technique that allows more sensitive detection of HPV DNA than any other hybridization method and enables the analysis of several HPV types in the same sample instead of only one HPV type in the scrapes.
authors.affiliation: Department of Clinical Microbiology, University of Kuopio, Finland.
authors.forename: S
authors.initials: S
authors.lastname: Parkkinen
authors.forename: S
authors.initials: S
authors.lastname: Syrjänen
authors.forename: K
authors.initials: K
authors.lastname: Syrjänen
authors.forename: M
authors.initials: M
authors.lastname: Yliskoski
authors.forename: J
authors.initials: J
authors.lastname: Tenhunen
authors.forename: R
authors.initials: R
authors.lastname: Mäntyjärvi
authors.forename: M
authors.initials: M
authors.lastname: Ranki
mesh_terms: D004279:DNA, Viral / Q000032:analysis* / Q000235:genetics; D005260:Female; D005500:Follow-Up Studies; D005821:Genetic Techniques; D006801:Humans; D009693:Nucleic Acid Hybridization; D065006:Papanicolaou Test; D027383:Papillomaviridae / Q000235:genetics*; D011230:Precancerous Conditions / Q000032:analysis* / Q000175:diagnosis / Q000235:genetics; D011446:Prospective Studies; D014412:Tumor Virus Infections / Q000032:analysis* / Q000175:diagnosis / Q000235:genetics; D002583:Uterine Cervical Neoplasms / Q000032:analysis* / Q000175:diagnosis / Q000235:genetics; D014626:Vaginal Smears
chemical_list: D004279:DNA, Viral